Biotechnology

AppYea Launches E-Commerce Store on Amazon Broadening Distribution

March 20, 2024 11:45 AM

AppySleep smart wristband now available on Amazon Successful fulfillment of all pre-orders Entering the 17.9 Billion Sleep Tech Device Market GAN YAVNE, ISRAEL / ACCESSWIRE / March 20, 2024 / AppYea, Inc. (OTCQB:APYP), developer of an innovative and accurate wearable monitoring solution to treat sleep apnea and snoring, today announced the launch of its new e-commerce store on Amazon. AppYea recently commenced its commercial phase, with the...

Read more

Minutes from Annual General Meeting in FluoGuide A/S

March 20, 2024 9:45 AM

COPENHAGEN, DENMARK / ACCESSWIRE / March 20, 2024 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company") held its annual general meeting on 20 March 2024. To the shareholders of FluoGuide A/S The Annual General Meeting was held Wednesday 20 March 2024 at 09:00 AM (CET) at the Company's premises, Ole Maaløes Vej 3, room M0.08 - Oxygen, DK-2200 Copenhagen N, Denmark. Notice: Represented at the annual general meeting was share capital of nominal...

Read more

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

March 20, 2024 8:30 AM

SINGAPORE / ACCESSWIRE / March 20, 2024 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company that focuses on utilizing its licensed proprietary technologies to create novel allogeneic cell-based immunotherapies for treating a range of cancers, recently announced that it has entered into a research collaboration agreement with Sengkang General Hospital Pte Ltd., a public hospital in...

Read more

AbTherx Appoints Jessica Stark, PhD, as Scientific Advisor

March 20, 2024 6:00 AM

Glycoimmunology expert and co-inventor of AbLec technology joins AbTherx to expand expertise around challenging drug targets MOUNTAIN VIEW, CA / ACCESSWIRE / March 20, 2024 / AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, today announced the appointment of Jessica Stark, PhD, as a scientific advisor. In her new role, Dr. Stark will provide guidance on the company's research...

Read more

SingleTimeMicroneedles, CEO Jasdeep Singh, Wins 2024 SXSW Pitch Competition

March 19, 2024 9:00 AM

SingleTimeMicroneedles wins the Food, Nutrition, and Health Category. STORRS, CT / ACCESSWIRE / March 19, 2024 / SingleTimeMicroneedles, Inc., a microneedle drug development and delivery company, was selected as the winner of the Food, Nutrition, and Health category for the 15th annual SXSW Pitch (formerly SXSW Accelerator). SingleTimeMicroneedles STM and Jasdeep Singh In a field of winners dominated by artificial intelligence companies, STM...

Read more

Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider

March 19, 2024 9:00 AM

Petros begins enrollment in AI integrated Human Factors Study to optimize self-screening, continuing its efforts to make STENDRA (avanafil) the first erectile dysfunction medication to achieve OTC Status (Please see important safety information below) NEW YORK, NY / ACCESSWIRE / March 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug...

Read more

Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System

March 19, 2024 8:00 AM

NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray®"), a clinical and commercial stage drug delivery technology company, announced today a collaboration to develop an alternative delivery mechanism for patients who can...

Read more

CB Scientific, Inc. Concludes its Annual Meeting of Stockholders

March 19, 2024 7:00 AM

Shareholders endorse name change to Cardiac Biotech Solutions, Inc. subject to regulatory approval LAS VEGAS, NV / ACCESSWIRE / March 19, 2024 / CB Scientific, Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the company successfully concluded its Annual Meeting of Stockholders ("Annual Meeting") on Thursday, March 14,...

Read more

Canopus Biopharma Inc. (CBIA) dba Blue Heaven Coffee Inc. (BHC) Announces and Secures New Unattended Retail Management Platform - Parlevel systems (VMS)

March 19, 2024 7:00 AM

LAS VEGAS, NV / ACCESSWIRE / March 19, 2024 / Canopus Biopharma Inc. (OTC PINK:CBIA) dba Blue Heaven Coffee Inc. (BHC) has partnered with Parlevel Systems to assist with the optimization of its vending, micro market, and unattended retail operations. Parlevel, recognized as the fastest-growing provider of vending management systems (VMS) for vending operators and office coffee service (OCS) providers, offers innovative solutions tailored to...

Read more

Deverra Therapeutics Granted FDA Regenerative Medicine Advanced Therapy and Orphan Drug Designations for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid Leukemia

March 19, 2024 6:00 AM

Designations Validate Preliminary Data and Enhances Ability to Offer Dilanubicel to Cancer Patients SEATTLE, WA / ACCESSWIRE / March 19, 2024 / Deverra Therapeutics Inc., a clinical-stage biotechnology company developing allogeneic universal donor cell therapy treatments to fight cancer and other life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy...

Read more

Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis

March 19, 2024 3:20 AM

STOCKHOLM, SE / ACCESSWIRE / March 19, 2024 / Vicore Pharma Holding (STO:VICO) AlmeeTM is the first digital therapy to address anxiety and quality of life in patients living with pulmonary fibrosis (PF). AlmeeTM has shown effectiveness in reducing anxiety symptoms and improving health-related quality of life in the COMPANION study as reported earlier this year, driving a 2.7-point increase in GAD-7 score and a 4.4 improvement in KBILD score...

Read more

Biovica rReceives Positive Patent Notification for Immunotherapies

March 19, 2024 3:20 AM

UPPSALA, SE / ACCESSWIRE / March 19, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has received a positive International Preliminary Report on Patentability (IPRP) covering the use of TKa as a prognostic and monitoring marker in cancer treatment outside the CDK 4/6 inhibitor space, expanding the market potential for the DiviTum TKa technology by four to six times. "This is a...

Read more

Eyam Welcomes Wolfgang Koester to Board of Directors

March 18, 2024 7:30 AM

VANCOUVER, BC / ACCESSWIRE / March 18, 2024 / Eyam Vaccines and Immunotherapeutics is pleased to announce the appointment of Wolfgang Koester to the Board of Directors, one of the "100 Most Influential People in Finance". This strategic addition underscores Eyam's commitment to increase collaboration with global companies on their proven AI driven bioinformatics platform and innovative self-amplifying platforms to design and deliver vaccines...

Read more

Cambridge Isotope Laboratories, Inc. (CIL) Announces Relocation of Corporate Headquarters and Expansion of Research & Development and cGMP Production

March 15, 2024 9:00 AM

New Location Positions CIL for Product Development and Future Growth TEWKSBURY, MA / ACCESSWIRE / March 15, 2024 / Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), has announced it will be relocating and expanding its corporate headquarters to newly purchased space in Tewksbury, MA, to advance the operations and growth of the company. The purchase was made in June...

Read more

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity

March 15, 2024 9:00 AM

Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, March 21st at 12:00 PM ET IRVINE, CA / ACCESSWIRE / March 15, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that it will present at the Virtual Investor Lunch Break: The enVVeno Opportunity event on Thursday, March 21, 2024 at...

Read more

Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results

March 15, 2024 8:00 AM

Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical Plans SAN DIEGO, CA / ACCESSWIRE / March 15, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today reported financial results for the fourth quarter and full year of 2023. Dr....

Read more

Ondine Biomedical Inc. Announces Steriwave Deploying in Eight New Sites

March 15, 2024 3:00 AM

Steriwave deploying in eight new sites VANCOUVER, BC / ACCESSWIRE / March 15, 2024 / Ondine Biomedical Inc. (LON:OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments to prevent and treat healthcare-associated infections (HAIs), has made significant commercial progress to date in 2024, ahead of management's expectations. Ondine's Steriwave® technology is deploying in eight new healthcare facilities,...

Read more

Lexaria Appoints Nelson Cabatuan as Chief Financial Officer

March 14, 2024 9:20 AM

KELOWNA, BC / ACCESSWIRE / March 14, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. As a member of the executive leadership team, Mr. Cabatuan will lead the Company's financial operations. "Nelson's deep financial leadership experience will be...

Read more

Form Bio Helps Life Sciences Professionals Transform Omics Data Into Breakthrough Insights Through Google Cloud

March 14, 2024 8:00 AM

Google Cloud's Powerful AI Models for Healthcare and Life Sciences Research Now Available as Point-and-Click Workflows via Form Bio's Bioinformatics Platform, Available on Google Cloud Marketplace DALLAS, TX / ACCESSWIRE / March 14, 2024 / Form Bio, the breakthrough computational life sciences solutions provider, today announced the availability of Google Cloud's innovative AI-based models for healthcare and life sciences research as...

Read more

Q3 Interim Report November-January 2023/2024

March 14, 2024 3:20 AM

UPPSALA, SE / ACCESSWIRE / March 14, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Several new commercial agreements signed and evidence that DiviTum® TKa significantly improves clinical routines in the USA. SEK t Q3 23/24 Q3 22/23 May-Jan 23/24 May-Jan 22/23 Full year 22/23 Net sales 1,075 926 5,391 2,432 3,383 Operating profit (loss) -27,848 -29,277 -85,355 -73,250 -110,457 Earnings per share, after dilution -0.44 -0.64...

Read more